Entest Biomedical Company Top Insiders
| ETNI Stock | USD 0.0002 0.00 0.00% |
Entest Biomedical employs about 4 people. The company is managed by 3 executives with a total tenure of roughly 7 years, averaging almost 2.0 years of service per executive, having 1.33 employees per reported executive. Assessment of Entest Biomedical's management performance can provide insight into the firm performance.
| Peiwen Yu CEO President CEO, Director |
Entest |
Entest Biomedical Management Team Effectiveness
Entest Biomedical's management efficiency ratios could be used to measure how well Entest Biomedical manages its routine affairs as well as how well it operates its assets and liabilities.Entest Biomedical Workforce Comparison
Entest Biomedical is rated # 4 in number of employees category among its peers. The total workforce of Shell Companies industry is currently estimated at about 101. Entest Biomedical holds roughly 4.0 in number of employees claiming about 4% of equities listed under Shell Companies industry.
Entest Biomedical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Entest Biomedical Price Series Summation is a cross summation of Entest Biomedical price series and its benchmark/peer.
Entest Biomedical Notable Stakeholders
An Entest Biomedical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Entest Biomedical often face trade-offs trying to please all of them. Entest Biomedical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Entest Biomedical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Peiwen Yu | President CEO, Director | Profile | |
| Steven Josephs | Chief Board | Profile | |
| Feng Lin | Director Board | Profile |
About Entest Biomedical Management Performance
The success or failure of an entity such as Entest Biomedical often depends on how effective the management is. Entest Biomedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Entest management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Entest management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It intends to seek business opportunities to review and analyze for purposes of effecting a merger, acquisition, or other business combination with an operating company business. Entest Group, Inc. was founded in 2008 and is based in Shenzhen, China. Entest is traded on OTC Exchange in the United States.
Entest Biomedical Workforce Analysis
Traditionally, organizations such as Entest Biomedical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Entest Biomedical within its industry.Entest Biomedical Manpower Efficiency
Return on Entest Biomedical Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Income Per Employee | 47.9K | |
| Net Income Per Executive | 63.9K |
Complementary Tools for Entest Pink Sheet analysis
When running Entest Biomedical's price analysis, check to measure Entest Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entest Biomedical is operating at the current time. Most of Entest Biomedical's value examination focuses on studying past and present price action to predict the probability of Entest Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entest Biomedical's price. Additionally, you may evaluate how the addition of Entest Biomedical to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |